Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 29208675)

Published in Gut on December 05, 2017


Lorenzo Fuccio1, Alessandro Repici2, Cesare Hassan3, Thierry Ponchon4, Pradeep Bhandari5, Rodrigo Jover6, Konstantinos Triantafyllou7, Daniele Mandolesi1, Leonardo Frazzoni1, Cristina Bellisario8, Franco Bazzoli1, Prateek Sharma9,10, Thomas Rösch11, Douglas K Rex12

Author Affiliations

1: Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
2: Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Research and University Hospital, Rozzano, Italy.
3: Nuovo Regina Margherita Hospital, Rome, Italy.
4: Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.
5: Queen Alexandra Hospital, Portsmouth, UK.
6: Service of Digestive Medicine, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain.
7: Ηepatogastroenterology Unit, Second Department of Internal Medicine, Research Institute and Diabetes Center, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, Athens, Greece.
8: Department of Cancer Screening, Centre for Epidemiology and Prevention in Oncology (CPO), University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.
9: Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas, Missouri, USA.
10: Department of Gastroenterology, Veteran Affairs Medical Center, Kansas, Missouri, USA.
11: Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
12: Division of Gastroenterology/Hepatology, Indiana University Hospital, Indianapolis, Indiana, USA.

Articles by these authors

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy (2020) 3.93

Split dosing with a low-volume preparation is not inferior to split dosing with a high-volume preparation for bowel cleansing in patients with a history of colorectal resection: a randomized trial. Endoscopy (2015) 2.64

Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol (2013) 2.37

Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia. Gastrointest Endosc (2017) 1.96

Development of a prediction model of adverse events after stent placement for esophageal cancer. Gastrointest Endosc (2015) 1.59

Clinical outcomes following stent placement in refractory benign esophageal stricture: a systematic review and meta-analysis. Endoscopy (2015) 1.48

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol (2016) 1.40

BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17

EUS-guided gold fiducial placement and migration rate. Gastrointest Endosc (2014) 1.11

The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy (2015) 1.08

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy (2016) 0.99

Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut (2015) 0.96

The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc (2013) 0.91

Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection. Gut (2014) 0.90

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy (2017) 0.86

The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. United European Gastroenterol J (2015) 0.81

Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma. Cancer Med (2015) 0.81

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J (2017) 0.78

Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77

Endoscopic mucosal resection of large colorectal adenomas: Only for expert centers? United European Gastroenterol J (2015) 0.77

Early adverse events of per-oral endoscopic myotomy. Gastrointest Endosc (2016) 0.77

Probiotics in the Treatment of Diverticular Disease. A Systematic Review. J Gastrointestin Liver Dis (2016) 0.76

The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk. Cancer Med (2016) 0.76

A novel prepless X-ray imaging capsule for colon cancer screening. Gut (2015) 0.76

Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis. Gastrointest Endosc (2017) 0.76

A 28-year-old woman with hypertrophic right leg and haematochezia. Gut (2015) 0.75

A 52-year-old man with heartburn and weight loss. Gut (2015) 0.75

Recovery of endoscopy services in the era of COVID-19: recommendations from an international Delphi consensus. Gut (2020) 0.75

Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients. Gut (2017) 0.75

Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection. JAMA Intern Med (2014) 0.75

Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer. Gastrointest Endosc (2015) 0.75

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol (2016) 0.75